Literature DB >> 15000269

CRC screening: review of the evidence and suggestions on when and how to move on from randomized trials to screening programmes.

G Hoff1.   

Abstract

Mesh:

Year:  2004        PMID: 15000269     DOI: 10.1080/00365520410004488

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  5 in total

1.  Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).

Authors:  G Hoff; T Grotmol; E Thiis-Evensen; M Bretthauer; G Gondal; M H Vatn
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals.

Authors:  Inger K Larsen; Tom Grotmol; Kari Almendingen; Geir Hoff
Journal:  BMC Gastroenterol       Date:  2006-01-13       Impact factor: 3.067

3.  The science and politics of colorectal cancer screening.

Authors:  Geir Hoff; Michael Bretthauer
Journal:  PLoS Med       Date:  2006-01-03       Impact factor: 11.069

4.  Barriers related to fecal occult blood test for colorectal cancer screening in moderate risk individuals.

Authors:  Seyed Homamodin Javadzade; Mahnoush Reisi; Firouze Mostafavi; Akabar Babaei Heydarabadi; Elahe Tavassoli; Gholamreza Sharifirad
Journal:  J Educ Health Promot       Date:  2014-11-29

5.  Appointments timed in proximity to annual milestones and compliance with screening: randomised controlled trial.

Authors:  Geir Hoff; Michael Bretthauer
Journal:  BMJ       Date:  2008-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.